Log In
BCIQ
Print this Print this
 

lifastuzumab (RG7599)

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionAnti-NaPi2b, DNIB0600A antibody drug conjugate (ADC)
Molecular Target Solute carrier family 34 sodium phosphate member 2 (SLC34A2) (NaPi2b)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today